Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)
Clinical trial NCT02624869 · COMPLETED
Trial details
- NCT number
- NCT02624869
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-10
- Primary completion
- 2021-06-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.